![](https://medcitynews.com/wp-content/uploads/sites/7/2021/05/Zachary-Sweeney_CEO.jpg)
Backed by $92M, startup Interline aims to shed new light on protein communities
Interline Therapeutics has technology that shows how proteins interact as communities, paving the way for the discovery of new drugs. CEO Zachary Sweeney, a Denali Therapeutics veteran, said the startup will use the $92 million in funding to advance programs in cancer and inflammatory diseases.